102 related articles for article (PubMed ID: 3934585)
1. Relationship of dose to the reactogenicity and immunogenicity of meningococcal polysaccharide vaccines in adults.
Griffiss JM; Brandt BL; Broud DD; Altieri PL; Berman SL
Mil Med; 1985 Oct; 150(10):529-33. PubMed ID: 3934585
[No Abstract] [Full Text] [Related]
2. Immunogenicity of O-acetyl-negative and -positive polysaccharide vaccines for infections with Neisseria meningitidis group C in infants.
Pichichero M; Anderson P; Gotschlich E; Kamm J; McMullen A; Nielsen S
J Infect Dis; 1985 Oct; 152(4):850-1. PubMed ID: 3930623
[No Abstract] [Full Text] [Related]
3. Effectiveness of BC meningococcal vaccine in Brazil.
Nishioka S
Int J Epidemiol; 1996 Oct; 25(5):1102-3. PubMed ID: 8921501
[No Abstract] [Full Text] [Related]
4. Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children.
Lepow ML; Beeler J; Randolph M; Samuelson JS; Hankins WA
J Infect Dis; 1986 Dec; 154(6):1033-6. PubMed ID: 3097160
[No Abstract] [Full Text] [Related]
5. Defences against meningococcal infections.
Lancet; 1985 Oct; 2(8461):929-30. PubMed ID: 2865427
[No Abstract] [Full Text] [Related]
6. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
Wu C
Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
[No Abstract] [Full Text] [Related]
7. [Anti-meningococcal vaccine: myth and reality].
Nassif X
Arch Pediatr; 1999; 6 Suppl 3():647s-649s. PubMed ID: 10429807
[No Abstract] [Full Text] [Related]
8. [Comparative study of the reactogenicity and immunogenicity of various doses of a chemical polysaccharide meningococcal vaccine administered by syringe and jet injector].
Pavlova LI; Nefedova LA; Nikitiuk NM; Chernysheva TF; Alliluev AP
Zh Mikrobiol Epidemiol Immunobiol; 1983 Nov; (11):58-64. PubMed ID: 6419514
[TBL] [Abstract][Full Text] [Related]
9. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
Jennings HJ
Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
[No Abstract] [Full Text] [Related]
10. [Report of the 3d International Conference on the immunology of meningococcal meningitis. Current status of meningococcus B vaccine].
Del Real G
Rev Sanid Hig Publica (Madr); 1979; 53(11-12):1639-49. PubMed ID: 45419
[No Abstract] [Full Text] [Related]
11. Meningococcal vaccines.
Bethell D; Pollard AJ
Expert Rev Vaccines; 2002 Jun; 1(1):75-84. PubMed ID: 12908514
[TBL] [Abstract][Full Text] [Related]
12. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.
Ambrosch F; Wiedermann G; Crooy P; George AM
Bull World Health Organ; 1983; 61(2):317-23. PubMed ID: 6407768
[TBL] [Abstract][Full Text] [Related]
14. [Interpretation of the laboratory results concerning the protective effect of vaccines].
Berrón Morato S; Sanz Moreno JC; Martín García E; Salcedo Peláez C; Bermúdez Saugar MP; Vázquez Moreno JA
Rev Esp Salud Publica; 1998; 72(5):431-3. PubMed ID: 9951337
[No Abstract] [Full Text] [Related]
15. [Vaccines against Neisseria meningitidis].
Ferrón L; Criado MT; Ferreirós CM
Enferm Infecc Microbiol Clin; 1992 May; 10(5):296-301. PubMed ID: 1391002
[No Abstract] [Full Text] [Related]
16. Vaccine for meningococcal meningitis tested.
Marwick C
JAMA; 1991 Oct; 266(15):2052-3. PubMed ID: 1920685
[No Abstract] [Full Text] [Related]
17. [Comparative study of the sensitivity and specificity of dried and liquid meningococcal erythrocyte diagnostic agents A, C and Y in a controlled trial].
Nikitiuk NM; Sumarokov AA; Nefedova LA; Pavlova LI; Kostiukova NN
Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):72-6. PubMed ID: 6435359
[TBL] [Abstract][Full Text] [Related]
18. [efficacy of the polysaccharide vaccine of Neisseria meningitidis group A].
Yuan CD
Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):207-10. PubMed ID: 6416682
[No Abstract] [Full Text] [Related]
19. Bacterial outer membrane protein vaccines. The meningococcal example.
Poolman JT
Adv Exp Med Biol; 1996; 397():73-7. PubMed ID: 8718585
[No Abstract] [Full Text] [Related]
20. [Serological evaluation of polyvalent A-C anti-meningococcal vaccine in Chile].
García Moreno J; Prat Miranda MS; Vicent P; Calderón B
Bol Oficina Sanit Panam; 1982 Aug; 93(2):149-57. PubMed ID: 6215047
[No Abstract] [Full Text] [Related]
[Next] [New Search]
